Large-scale study of NSAIDS finds no link to heart attack
Celebrex is less likely than naproxen and ibuprofen to cause kidney and gastrointestinal problems
Add BT as a preferred sourceDeeperDive is a beta AI feature. Refer to full articles for the facts.
Washington
IN 2004, when drugmaker Merck voluntarily pulled the pain-reliever Vioxx off the market amid evidence that it increased the risk of heart attacks, concern naturally turned to its nearly identical rival, Celebrex.
The medication works the same way, by inhibiting production of an enzyme that causes pain and inflammation - as do naproxen, ibuprofen and others in the class of widely used analgesics known as non-steroidal anti-inflammatory drugs (NSAIDS).
Share with us your feedback on BT's products and services
TRENDING NOW
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
OCBC is said to emerge as lead bidder for HSBC Indonesia assets
Middle East-linked energy supply shocks put Asean Power Grid back in focus
Eurokars Group introduces rental car franchises Enterprise Rent-A-Car, National Car Rental, and Alamo to Singapore
